Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rifaximin for Immune Dysfunction in Cirrhosis and HE
NCT02019784Phase 4Completed
- Sponsor
- King's College Hospital
- Start
- Jan 2015
- Primary completion
- Jun 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of rifaximin in hepatic encephalopathy (HE), sponsored by King's College Hospital. Started Jan 2015; status: completed.
02
Drugs
rifaximin
03
Conditions
hepatic encephalopathy (HE)
Beyond the preview
Go deeper on NCT02019784.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02019784.